Event dossier

Peptide user tore oesophagus after using counterfeit product, Australian regulator warns

TGA issues alert after person was hospitalised after believing they were taking experimental weight loss drug retatrutide Follow our Australia news live blog for latest updates Get our breaking news email , free app or…

1 report1 sourceSep 14, 2026, 2:41 AM
FilterThe Guardian
Clustered coverageThe Guardian
Coverage timeline1
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

The GuardianSep 14, 2026, 2:41 AM

Peptide user tore oesophagus after using counterfeit product, Australian regulator warns

TGA issues alert after person was hospitalised after believing they were taking experimental weight loss drug retatrutide Follow our Australia news live blog for latest updates Get our breaking news email , free app or daily news podcast A patient who tore their oesophagus after taking a counterfeit version of an experimental weight loss drug has prompted Australia’s medicines regulator to warn of serious risks of such products. The concern relates to retatrutide, a type of drug known as a peptide . Retatrutide has not been approved by the Therapeutic Goods Administration (TGA) or regulators overseas, and it cannot be legally prescribed or sold in Australia. Continue reading...

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.

El Psy Congroo